2015•Unpublished venueRequires access

Treatment advances in mucosa-associated lymphoid tissue lymphoma

Feifei Wu

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma originates from outside of the lymph nodes, which is a kind of low-grade malignant lymphoma and the most type of marginal zone lymphoma (MZL). It accounts for about 30 %-50 % of the indolent NHL. The onsets and therapies of MALT lymphoma are diverse. This article focuses on the recent therapeutic advances of MALT lymphoma. Key words: Lymphoma, non-Hodgkin; Mucosa-associated lymphoid tissue lymphoma; Drug therapy; Radiotherapy; Surgical procedures, operative

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Lymphoma, MALT lymphoma, Mucosa-associated lymphoid tissue, Lymphatic system, Marginal zone, Medicine, Pathology, Radiation therapy